You are here: Fairness.com > Resources > Pfizer Inc.

Pfizer Inc.


Self Description

July 2002: "The new Pfizer unites the two fastest-growing health care companies. It creates the world's largest and most talented biomedical research organization. It puts the combined power of the industry's best sales, marketing, and manufacturing operations behind a portfolio that includes eight $1 billion prescription medicines and the world's most comprehensive animal health business." http://www.pfizer.com/pfizerinc/about/focus/preeminent_intro.htm

Third-Party Descriptions

May 2010: "Ms. McClain, now 52, says she has suffered bouts of temporary paralysis after being infected by a genetically engineered virus at the Groton lab. A jury last month awarded Ms. McClain $1.37 million, saying Pfizer had fired her for raising questions about laboratory safety."

http://www.nytimes.com/2010/05/28/business/28hazard.html

March 2010: "What Loucks, who was acting U.S. attorney in Boston until November, didn't know until years later was that Pfizer managers were breaking that pledge not to practice off-label marketing even before the ink was dry on their plea."

http://www.washingtonpost.com/wp-dyn/content/article/2010/03/19/AR2010031905578.html

January 2008: 'One major pharmaceutical company, Pfizer, declined to buy drug ingredients from Shanghai Pharmaceutical Group because of quality-related issues, said Christopher Loder, a Pfizer spokesman. In 2006, Pfizer agreed to evaluate Shanghai Pharmaceutical Group’s “capabilities” as an ingredient supplier, but so far the company “has not met the standards required by Pfizer,” Mr. Loder said in a statement.'

http://www.nytimes.com/2008/01/31/world/asia/31pharma.html

January 2008: "Fibromyalgia is a real disease. Or so says Pfizer in a new television advertising campaign for Lyrica, the first medicine approved to treat the pain condition, whose very existence is questioned by some doctors."

http://www.nytimes.com/2008/01/14/health/14pain.html

April 2007: In 2005, a federal judge ruled as false and misleading a Listerine mouthwash ad campaign by Pfizer (PFE). The ad claimed that Listerine was as effective as flossing in fighting tooth and gum decay. The judge in that suit ruled that the claim even poses a public health risk.

http://www.businessweek.com/bwdaily/dnflash/content/apr2007/db20070404_698651.htm

January 2007: Twenty-seven members of the pharmaceutical manufacturers organization have endorsed the guidelines, but it is hard to figure exactly how long the delays in advertising will run. Bristol-Myers Squibb has said that it would delay for 12 months. Johnson Johnson & Johnson and Pfizer Johnson and Pfizer said they would wait six months. The manufacturers group cannot say how other companies have interpreted the guidelines, a spokesman said.

http://www.nytimes.com/2007/01/22/business/media/22drug.html

November 2006: But Lilly is hardly alone in benefiting. Pfizer, the world’s largest drug maker, said its sales soared 14 percent in the United States in the third quarter, while rising only 3 percent internationally. Over all, Pfizer said its profits more than doubled, to $3.4 billion from $1.6 billion, though part of the difference came from high one-time charges last year.

http://www.nytimes.com/2006/11/06/business/06drug.html

May 2006: In 1999, 300 pet owners filed a lawsuit against Pfizer Inc., alleging that its early dog arthritis medicine Rimadyl had seriously harmed their pets. Pfizer settled in 2003, saying it had done nothing wrong but wanted to avoid costly litigation. Each plaintiff was given $1,000.

http://www.washingtonpost.com/wp-dyn/content/article/2006/05/11/AR2006051101883.html

May 2006: A panel of Nigerian medical experts has concluded that Pfizer Inc. violated international law during a 1996 epidemic by testing an unapproved drug on children with brain infections at a field hospital.

http://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html

August 2004: Pfizer, the maker of Zoloft, has helped the county solicitor who is prosecuting Christopher Pittman. Plaintiffs' lawyers from Houston and Los Angeles, who between them have brought numerous civil lawsuits against Pfizer and other antidepressant makers, have signed onto the defense team. Groups opposed to pediatric antidepressant use have also championed the boy's case, which is being played out in Chester, S.C., a small town near the North Carolina border.

http://www.nytimes.com/2004/08/23/business/23drug.html

January 2005: ...in 2003 the pharmaceutical industry invested $33.2 billion in drug research. That does not include the nearly $30 billion spent on life sciences by the publicly financed National Institutes of Health, which pays for research that leads to commercial drugs. Weaken the drug industry and you weaken one pillar of the U.S. economy. And Pfizer's trouble with Viagra in China demonstrates just how vulnerable the American knowledge economy is in a world where ideas ''protected'' by our laws trade freely nonetheless.

http://www.nytimes.com/2005/01/09/magazine/09COUNTERFEIT.html

Relationships

RoleNameTypeLast Updated
Status/Name Change from Parke-Davis Organization Jul 29, 2011
Owner of (partial or full, past or present) Pharmacia and Upjohn Organization Mar 23, 2010
Owner of (partial or full, past or present) Warner-Lambert Organization Mar 23, 2010
Employee/Freelancer/Contractor (past or present) David Franklin Person Aug 8, 2004
Financial Supporter of (past or present) Dr. Robert Jarvik M.D. Person Feb 12, 2008
Organization Head/Leader (past or present) Jeffrey B. Kindler Person Apr 27, 2008
Employee/Freelancer/Contractor (past or present) Dr. Eleanor Perfetto Ph.D. Person Apr 8, 2010
Opponent (past or present) Organization Executive (past or present) Dr. Peter Rost M.D. Person Jun 6, 2007
Financial Supporter of (past or present) Noah Wyle Person Jun 19, 2005

Articles and Resources

59 Articles and Resources. Go to:  [Previous 20]

Date Fairness.com Resource Read it at:
Jan 09, 2005 Manufaketure

QUOTE: ...pharmacies also represent a current and urgent battleground in one of the most important struggles between the developed world and China's surging economic power. This is the fight over intellectual property and the related investments essential to the knowledge economy, that amorphously defined new world in which better ideas, not faster, cheaper hands create jobs and wealth. Despite their appearances, Chinese pharmacies are stocked with expertly copied versions of some of the world's most profitable medicines, patented products that generate hundreds of billions of dollars' worth of business in the United States, Europe and Japan. Even the very latest miracle drugs sell in China for a fraction, often one-tenth or less, of what their authorized equivalents in the United States cost.

 New York Times
Nov 19, 2004 FDA Officer Suggests Strict Curbs on 5 Drugs: Makers Dispute Claims About Health Risks

QUOTE: Describing the agency he works for as incapable of stopping dangerous drugs from entering and staying on the market, David J. Graham, associate director of the Office of Drug Safety, told the senators that the FDA's role in reviewing and approving new drugs sometimes conflicts with its duty to address safety issues.

 Washington Post
Nov 14, 2004 Despite Warnings, Drug Giant Took Long Path to Vioxx Recall

QUOTE: Merck decided not to conduct a study solely to determine whether Vioxx might cause heart attacks and strokes - the type of study that outside scientists would repeatedly call for as clinical evidence continued to show cardiovascular risks from the drug.

 New York Times
Sep 24, 2004 FDA Told Its Analyst to Censor Data on Antidepressants

QUOTE: A Food and Drug Administration medical officer was told by top agency officials to delete material on the risks of antidepressant drugs from records he was submitting to Congress and then to conceal the deletions...

 Washington Post
Aug 23, 2004 A DRUG ON TRIAL: Justice and Science; Boy's Murder Case Entangled In Fight Over Antidepressants

QUOTE: While prosecutors portray him as a troubled killer, his defenders say the killings occurred for a reason beyond the boy's control - a reaction to the antidepressant Zoloft, a drug he had started taking for depression not long before the slayings. Such defenses, which have been used before, have rarely succeeded.

 New York Times
Jul 29, 2004 Whistle-blowers form a breed apart

QUOTE: With or without the backing of the federal government, some people can't imagine keeping quiet when they witness what they believe is wrongdoing.

 USA TODAY
Jul 25, 2004 In a Shift, Bush Moves to Block Medical Suits

QUOTE: The administration contends that consumers cannot recover damages for such injuries if the products have been approved by the Food and Drug Administration. In court papers, the Justice Department acknowledges that this position reflects a "change in governmental policy,"...

 New York Times
Jun 27, 2004 As Doctors Write Prescriptions, Drug Companies Write Checks

QUOTE: The check for $10,000 arrived in the mail unsolicited.Those checks and others, some of them said to be for six-figure sums, are under investigation by federal prosecutors in Boston as part of a broad government crackdown on the drug industry's marketing tactics.

 New York Times
May 14, 2004 Pfizer to Pay $420 Million in Illegal Marketing Case

QUOTE: Pfizer, the world's largest pharmaceutical company, pleaded guilty yesterday and agreed to pay $430 million to resolve criminal and civil charges that it paid doctors to prescribe its epilepsy drug, Neurontin, to patients with ailments that the drug was not federally approved to treat.

 New York Times
Jan 13, 2004 Putting a Price on a Good Night's Sleep

QUOTE: A new generation of sleeping pills is about to be marketed but experts are divided on both the actual need for them as well as their safety.

 New York Times
Aug 18, 2003 When Drug Prices Are Out Of Reach

QUOTE: Elderly and uninsured Americans pay the highest prices in the world for prescription drugs.

 US News & World Report
Mar 06, 2003 University's Drug Patent Is Invalidated by a Judge

QUOTE: ...the decision (to find the patent invalid) "confirms what we have said all along that the University of Rochester's patent was invalid on its face" and that the university "had no role in the discovery or development of Celebrex."

 New York Times
Dec 26, 2002 Drug Makers Battle Plan to Curb Rewards for Doctors

QUOTE: ...Bush administration plan to restrict gifts and other rewards that pharmaceutical manufacturers give doctors and insurers to encourage the prescribing of particular drugs....looked like illegal kickbacks.

 New York Times
Dec 04, 2002 Investigators Find Repeated Deception in Ads for Drugs

QUOTE: Some companies have repeatedly disseminated misleading advertisements for prescription drugs, even after being cited for violations, and millions of people see the deceptive commercials before the government tries to halt them...

 New York Times
Aug 13, 2002 Not-So-Fine Print: Patient Drug Leaflets Omit Key Warnings, Other Information

QUOTE: Committee members and experts who testified before the panel used words like "dismal" and "disgraceful" to describe the leaflets, which often contain the only detailed information consumers receive about the risks, benefits and side effects of the prescription drugs they take.

 Washington Post
Aug 11, 2002 Heartfelt Advice, Hefty Fees

QUOTE: In the last year or so, dozens of celebrities, from Ms. Bacall to Kathleen Turner to Rob Lowe, have been paid hefty fees to appear on television talk shows and morning news programs and to disclose intimate details of ailments that afflict them or people close to them. Often, they mention brand-name drugs without disclosing their financial ties to the medicine's maker.

 New York Times
Jul 16, 2002 Reforms Underway At Some Companies

QUOTE: In the wake of Coca-Cola Co.'s weekend announcement that it will formally recognize the cost of executive stock options, a number of other companies are considering similar steps...

 Washington Post
Dec 10, 2001 Drug Prices: What's Fair?

QUOTE: How can we encourage research and still keep prices within reach...for Cipro and beyond?

 BusinessWeek
Oct 26, 2001 Bayer Halves Price for Cipro, but Rivals Offer Drugs Free

QUOTE: while Bayer nearly halved its previous price, three big pharmaceutical companies have since stepped forward to offer large quantities of their antibiotics free if the Food and Drug Administration will approve their use for the treatment of anthrax.

 New York Times
Jul 23, 2001 Refusing to Let Go, Property Owners Test Eminent Domain's Limits

QUOTE: But when the seven property owners go to Superior Court here Monday, they will challenge a larger practice that needy cities everywhere have latched on to: using the power of eminent domain, or condemnation, to force property owners to turn over their land to private developers.

 New York Times

59 Articles and Resources. Go to:  [Previous 20]